BMC Urology

Section Editors

Steven Brandes, Washington University
Cosimo De Nunzio, Ospedale Sant'Andrea
John Gearhart, Johns Hopkins Children's Center
Debra E Irwin, University of North Carolina at Chapel Hill
Jose Karam, MD Anderson Cancer Center
Ercan Kocakoc, Bezmialem Vakif University
Salvatore Micali, University of Modena and Reggio Emilia
Charles J Rosser, University of Florida
Mostafa Taymour, University of Cairo

Executive Editor

Hayley Henderson, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

RBM3, a new biomarker in bladder cancer

Reduced RNA-binding motif protein 3 (RBM3) expression is associated with more aggressive tumours and reduced survival rates in patients with urothelial bladder cancer, and could be used as a prognostic biomarker for treatment stratification in patients with this disease.

BMC Urology 2013, 13:17
Diabetic impact on LUTS

Type 2 diabetes is associated with prevalent lower urinary tract symptoms (LUTS) in men, particularly those who are on active pharmaceutical treatment, but there is no association between type 2 diabetes and the onset of new LUTS.

BMC Urology 2013, 13:12
Perspectives on stone management

Marco Rosa et al. review new treatments and technologies in the management of renal and ureteral calculi, and discuss the promising advances expected from the use of robotic-assisted procedures.

BMC Urology 2013, 13:10
Prognostic markers in urinary bladder carcinoma

MDM2 SNP309 promoter polymorphism and p53 mutations are not associated with worse prognosis in primary T1 urinary bladder carcinoma patients, but abnormal p16 expression with mutated p53 gene shows increased rate of bladder cancer and shorter time to progression.

BMC Urology 2013, 13:5
Reviewing radiosensitizers in prostate cancer

Charles Rosser et al. review the efficacy of radiation therapy in prostate cancer and discuss the intrinsic microenvironment of tumours and how radiosensitizing agents may be used to improve the efficacy of radiation therapy.

BMC Urology 2013, 13:4
View more articles

RSS

Comments

mistake in figure 1

Comment on: Arlandis-Guzman et al. BMC Urology 2011, 11:9
Contraindications

Comment on: Weiss et al. BMC Urology 2010, 10:2
Related commentary published in BMC Urology

Comment on: Nakamura et al. BMC Urology 2009, 9:12

Hot topic

Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer

Mohammed MA, Seleim MF, Abdalla MS, Sharada HM and Abdel Wahab AHA

BMC Urology 2013, 13:25

Scope

BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

RSS

BMC series blog

15 May 2013: Call for papers: Health Policy and Systems in Emerging Economies

10 May 2013: Auf Wiedersehen ECCMID 2013

07 May 2013: Disease outcomes in ophthalmology – time for a multidisciplinary approach

Section Editor Profile

Cosimo De Nunzio, MD, PhD, is Consultant Urologist and contract Professor at the Department of Urology, Ospedale Sant'Andrea, University "La Sapienza", Roma, Italy. His research focus is prostatic disorders with a particular interest in voiding dysfunction, Benign prostatic Hyperplasia and prostate cancer diagnosis and management.

"I am pleased to be involved with BMC Urology first as a reviewer and now as Section Editor for Voiding Dysfunction. BMC Urology is an open access journal publishing original peer-reviewed articles, currently 10th on the SCImago Journal & Country Rank table and with and increasing number of manuscripts published in the last 4 years. When I joined BMC Urology, I have been particularly impressed by the excellent group of Section and Associate Editors involved in the Editorial Board and notwithstanding their young age, they are extremely expert in their field of interest. The journal's excellent editorial staff and the rapidity of the peer review process is another crucial quality of this journal. Moreover, I strongly support the open access platform used by BMC Urology which makes the specialized knowledge of urology more widely available to the scientific community at large, independently of the institutional affiliation or economic resources."

RSS